LESLIE DUNCAN: Open Payments
NPI 1265082978 · LAUREL, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,586 in 79 payments from 13 companies in 2025. Trend: 2023 $471 · 2024 $1,349 · 2025 $2,586
Food & beverage: $2,586
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $1,032 |
| Janssen Biotech, Inc. | 13 | $574 |
| PFIZER INC. | 10 | $316 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $214 |
| Amgen Inc. | 1 | $136 |
| Madrigal Pharmaceuticals | 4 | $127 |
| Lilly USA, LLC | 2 | $40 |
| Phathom Pharmaceuticals, Inc. | 2 | $38 |
| Digestive Care, Inc. | 1 | $33 |
| Regeneron Healthcare Solutions, Inc. | 1 | $20 |
Products named: TREMFYA, RINVOQ, SKYRIZI, VELSIPITY, ENTYVIO, CREON, REZDIFFRA, XELJANZ.
Industry payments across MD — which companies pay providers there.
